CorMedix Inc (CRMD) vs YD Bio Limited (YDES)

CorMedix Inc CRMD 5.67 +1.98%
YD Bio Limited YDES 6.98 +9.06%

CorMedix Inc and YD Bio Limited are both Biotechnology companies. CorMedix Inc and YD Bio Limited are of similar size ($453.0M and $433.4M).

Metric	CRMD	YDES	Biotechnology median
P/E	2.28	—	10.64
P/S	0.93	—	9.59
P/B	0.94	—	2.15
Price to free cash flow	1.72	—	26.07
EV/EBITDA	1.26	—	0.65
EV/Sales	0.69	—	9.45
Earnings yield	43.82%	—	(34.69%)
Free cash flow yield	58.04%	—	(24.02%)

Metric	CRMD	YDES	Biotechnology median
Gross margin	82.78%	—	65.59%
Operating margin	46.95%	—	0.00%
Net margin	40.49%	—	0.00%
Free cash flow margin	54.17%	—	0.00%
Return on equity	54.93%	—	(51.96%)
Return on assets	32.36%	—	(46.06%)
Return on invested capital	38.84%	—	0.00%

Metric	CRMD	YDES	Biotechnology median
Revenue growth (TTM)	280.50%	—	4.59%
EPS growth (last fiscal year)	780.00%	—	29.88%
Revenue growth, 5-year CAGR	305.79%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CRMD	YDES	Biotechnology median
Debt to equity	0.32	—	0.00
Current ratio	2.56	—	4.86
Net debt to EBITDA	(0.02)	—	1.01

Metric	CRMD	YDES	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	CRMD	YDES	Biotechnology median
Market cap	433.37m	453.04m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack